Navigation Links
Study Shows Newer Antiepileptic Drugs and Mood Stabilizers May be Safer Choice during Pregnancy
Date:7/17/2017

In a newly published journal issue of Birth Defects Research: Depression and Its Treatments during Pregnancy, studies take a closer look at maternal depression, its effects and the effects of various treatments of the disease on a developing baby with one study showing newer medications may be safer choices.

The scientific journal released today (see the Overview, doi: 10.1002/bdr2.1080) includes articles covering the impact untreated maternal depression may have on a developing fetus, factors to consider if treating depression in a pregnant patient (DOI: 10.1002/bdr2.1074), the potential effects of antidepressant use during pregnancy on pregnancy outcomes such as birth defects (DOI: 10.1002/bdr2.1078), and neurobehavioral development of children who were exposed to antidepressants in utero (DOI: 10.1002/bdr2.1076). “Understanding how to effectively treat depression in pregnant women and minimize risk to the developing fetus is critical,” explained Kembra Howdeshell, PhD, Health Scientist at the National Institute of Environmental Health Sciences and co-editor of the special issue of Birth Defects Research. “Nearly 13% of women experience depression during pregnancy and the rates after delivery are even higher.”

While the issue includes studies reviewing selective serotonin reuptake inhibitor (SSRI) use during pregnancy, one article led by Asher Ornoy, MD, the special issue’s co-editor who is a physician and researcher at Hebrew University Hadassah Medical School in Jerusalem, focused on the outcomes of pregnant women who used non-SSRI medications to treat depression. In their contribution “Antidepressants, antipsychotics and mood stabilizers in pregnancy: what do we know and how should we treat pregnant women with depression,” Dr. Ornoy and colleagues found that specific non-SSRIs, tricyclic and tetracyclic drugs, appear to be safe, while some mood stabilizers, such as lithium, valproic acid, carbamazepine and topiramate lead to birth defects if used during pregnancy (DOI: 10.1002/bdr2.1079). “We did find that newer antiepileptic drugs and mood stabilizers, such as lamotrigine and levetiracetam, do not appear to cause higher rates of birth defects,” said Dr. Ornoy. “They also did not appear to cause higher rates of neurodevelopmental alterations which is very encouraging,” he added.

Other topics covered in the issue include the role of serotonin in early brain development (DOI: 10.1002/bdr2.1085) and how SSRIs might alter it leading to possible long-term effects, and a review of antidepressant use during breastfeeding (DOI: 10.1002/bdr2.1077) and how most psychotropic medications that reach an infant through breastmilk don’t appear to have any effect on the baby. It also includes an article describing the epigenetics of clinical depression (DOI: 10.1002/bdr2.1081) and how the monitoring of certain genes may help to identify these non-DNA-coding changes to gene expression that are associated with life-long behavioral alterations in offspring of women diagnosed with clinical depression during pregnancy.

“Researchers are making advances toward effectively treating the pregnant patient’s depression while trying to reduce possible effects of treatment on the baby,” commented Dr. Howdeshell. “More research is needed to better understand how maternal depression and its medical treatment during pregnancy and breastfeeding may or may not alter psychosocial outcomes of exposed infants.”    

About the Teratology Society

The Teratology Society, an international professional group of scientists hailed as the premier source for cutting-edge research and authoritative information related to birth defects and developmentally mediated disorders, publishes Birth Defects Research with John Wiley & Sons. The Teratology Society is made up of more than 700 members worldwide specializing in a variety of disciplines related to birth defects research, including developmental biology and toxicology, reproduction and endocrinology, epidemiology, cell and molecular biology, nutritional biochemistry, and genetics as well as the clinical disciplines of prenatal medicine, pediatrics, obstetrics, neonatology, medical genetics, and teratogen risk counseling. Scientists interested in membership in the Teratology Society are encouraged to visit http://www.teratology.org.

Additional Public Resources
For more information on depression and the known effects of its treatments during pregnancy and while breastfeeding, please visit MotherToBaby and the March of Dimes.

Media Contact: Nicole Chavez, 619-368-3259, nchavez(at)teratology.org.

Read the full story at http://www.prweb.com/releases/Birth_Defects_Research/Depression_2017/prweb14500401.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Author Florencia Chang-Ageda's Newly Released “Divine Revelations-Eye Openers” is A Study in the Many Ways that Scripture can Inspire those Who are Open to His Word
2. Local Marketing: Study Shows Alternatives to Pain Medications can be Effective
3. Arlington, VA Dentist, Dr. Duke Kim, Attends Spear® Study Club, Offers Skilled Dental Implant Solutions
4. Orange County Dentist, Dr. A. Rassouli, Comments on the Study on How Increased Weight Could Affect Dental Risk
5. Canadian Zeolite Announces Positive Results on Two Year Study for the Remediation of Potash Brine-Impacted Groundwater
6. East LA Pediatric Dentist, Dr. Ramin Assili, Comments on the Study on Crooked Bites and What They Indicate
7. Study Shows Improper EHR Medical Coding Cause Inaccurate Medical Bills and Lost Revenue; EHR Shortcuts to Blame
8. Induced Pluripotent Stem Cells Combo Could Yield Much-needed Models to Study Vascular Disease
9. Author Del Hermosura’s Newly Released “Treasure The Treasure” Offers a Fun and Effective Way to Study the Bible
10. Bcureful Donates $30,000 to Fund Telemedicine and TSC Research Study
11. Study Shows Beautiful Smile Provides High Self-Esteem and Success—CDA Leads the Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... , ... August 11, 2018 , ... ... a Silver Stevie® Award in the Executive of the Year-Business category in The ... premier business awards program. All individuals and organizations worldwide – public and private, ...
(Date:8/9/2018)... (PRWEB) , ... August 09, ... ... quality and outcomes by simplifying medication adherence monitoring with Smart-pill bottle and ... DoseSmart® FHIR in the App Orchard. , The DoseSmart medication management and ...
(Date:8/7/2018)... ... August 07, 2018 , ... Sussex Vision Center, a ... Sky Vision. Michael Sussex, OD, founded the practice in Coldwater, and over the last ... Matt Austin, OD, to offer comprehensive eye health services for patients of all ages. ...
(Date:8/3/2018)... ... August 03, 2018 , ... On August 2, 2018 the JPML ordered that ... of Sadaka Associates, LLC has been litigating Zostavax injuries since 2011. ... on Multidistrict Litigation for the thousands of people injured by Zostavax, a vaccine given ...
(Date:8/2/2018)... Pa. (PRWEB) , ... August 02, 2018 , ... ... lifeIMAGE medical image e-sharing platform to connect clinicians inside and outside ... patients suffering a life-threatening stroke or trauma. , AHN joins other leading hospital ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... , ... August 02, 2018 , ... What: The Wharton ... Public Policy Funding, which will allow up to five business reporters who cover aspects ... program in Philadelphia this year. Each funding opportunity covers the cost of tuition, ...
(Date:8/2/2018)... ... 02, 2018 , ... Although there is a wealth of advice out there ... on a generalized “best practices” approach. But now doctors and their patients have a ... health. , Technology exists to help people find the right diet and personalized health ...
(Date:8/2/2018)... ... August 01, 2018 , ... Isagenix International , ... final five finalists in its annual total-body transformation program, the IsaBody Challenge®. They ... of Spartanburg, South Carolina; Christine Manukyan of Glendale, California; and Justin Whelan of ...
Breaking Medicine Technology: